cas 1795482-43-7|| where to buy 2-[5-(4-fluorophenyl)-1,3-oxazole-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

Produktname:2-[5-(4-fluorophenyl)-1,3-oxazole-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

IUPAC Name:2-[5-(4-fluorophenyl)-1,3-oxazole-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

: CAS：1795482-43-7; Molekulare Formel：C21H19FN2O4; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1795482-43-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1795482-43-7; Molekulare Formel:C21H19FN2O4; Schmelzpunkt:-; SMILES-Code:COC1=CC2=C(CN(CC2)C(=O)C2=NC=C(O2)C2=CC=C(F)C=C2)C=C1OC; Dichte:

: Katalognummer:CM833813; Molekulargewicht:382.39; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.